{"name":"Leap Therapeutics, Inc.","slug":"leap-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOQnhWMVpSd21YT3k1ZUVhb1dxTXVOdkt6TEJvVUd1T0xxVzZKVENKbkpBWk01dm9jbFpVMW1fVHJTdkxkbWhsY3BzblN5UV91MDU2RTEyd21xdkQ5aVNNZEhjRS1aSktIQlJ5cEwxQzhNcC1ZYmdJS1hKWm1GeFBPeHo3UTFSSHZlZ1lxVUhJbUJBQ3RBOVpYMWU1SW5ENHFkM0hTZ25BVEJXUQ?oc=5","date":"2025-11-12","type":"pipeline","source":"Fierce Biotech","summary":"Leap Therapeutics jumps from bio to crypto after winding down cancer program - Fierce Biotech","headline":"Leap Therapeutics jumps from bio to crypto after winding down cancer program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1oU3dyM1dobGc2OTZMSEpFZ0lqT1VFYlFyN2xwR3RmNWdoTVFHUkxqcWZlRWdEVHVaZUhfZjFLY3Y5SWhRbWlpYlZOQk9va2xOMWcwbEZvUVp2S182Smtv?oc=5","date":"2025-11-12","type":"pipeline","source":"ChartMill","summary":"LPTX Stock Price, Quote & Chart | LEAP THERAPEUTICS INC (NASDAQ:LPTX) - ChartMill","headline":"LPTX Stock Price, Quote & Chart | LEAP THERAPEUTICS INC (NASDAQ:LPTX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQblZScHladUpkWVVzX1EzSzJHcERqdU9BakluMUhoaDdPeTVBYm1zTUNYbUxDdkcxNVBHUUFhTUpteEphMzREdW16dTZFYk9pZjhfX1dROUVNNGlFa0Mya2o4MGZod0JXczRDbEFCTG43Y1RDUlV1VS12d2tialJMY21WVjc3NFBjQnVmY3NVOGptSG91WXdaTVRnTnRaTGN6MzJjU0h5T2M1dWJwbmtpbkpJVTl6cTR1QjVZ?oc=5","date":"2025-11-12","type":"pipeline","source":"Stock Titan","summary":"Cypherpunk (NASDAQ: LPTX) closes $58.88M placement, deploys $50M to Zcash - Stock Titan","headline":"Cypherpunk (NASDAQ: LPTX) closes $58.88M placement, deploys $50M to Zcash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOeXlSQkpUR0RDWXdBYUdqRmt1bGxzM3dmbmNiVk1ycUhDTDZPZDRtTVJQZWlSZy03MGVpRnpZX1IzcU1wT3Brdk5FZ1Zpck04SG1nbm1kT2J6SVpSX1FJaVVFRm11bW9RZ2cwbVRJaUJva1lxeldLcGpMUVBsaGNRZE8yOVJQUzA0YXZKWXR3UFhwcGNCc0w5clNzWHNiMDZ4TFVDeTZ3UDRwTmhMQml2b2VSS2pQNFYyRTRsVVRvNA?oc=5","date":"2025-11-12","type":"pipeline","source":"Stock Titan","summary":"Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy - Stock Titan","headline":"Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOVWJqZzNCOFFIa2pNSExRRWpwNHh2cUYxSkhKZ0NWU21YNlJ4MlBVTG1wZ0Mwc1BMQnk5NEd6bUszcUpHLW1rR1p5NEhqTDdkVnhtTjJaM3VTbk9uQmlMQmVUejRKTGYyRzY5blZ0bjVjYk5rNERKUV9CN3MwVm9WVFF1cWtxOGZjeTVSX1VGTDJJdUh5XzBvbmRua0YyRVFkbFplLUZtWERkS0FjNGd6RnpWWGpPZnY4NGlMVTFOdGVnNDA0?oc=5","date":"2025-10-20","type":"trial","source":"PR Newswire","summary":"Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025 - PR Newswire","headline":"Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxOTTdUNktJNzZBM2ZocEJXWmpWeG1MY0JESVRjQV9Pb2Y5eVc4eDZNQWtWcDhOSHQ3R2k4VlN6Z2RUOFZLbV9IY29ESlhUU2JrV1d3dnJ0RUMtRlduWExiUFZIRVd0NXRaa2xQeE03TURLcTJXNmJxVDc2VURXVGgtazNYMG8xQWdTWl9mQUdzWUJsVnIwOTZvV25VaVEzM3hJRlFaX3dvWDhLMmN5SS1rRzJ1bnZTTXlMdkdHTDRBMTdTT0VqX01CSGc0Y3lmV0RTVFRlM0RTQUJEQVFSd0RPUHFjb01tQWlISG1SQ29ZQ0xkV2FiYTFyVk5KU1ljcHhmdWRpRjFGTFlkZENTNGR1TS1ISmhGWW41a0gtTmthMlJVU0x2SmJmX2VGeUNvZ0xK?oc=5","date":"2025-10-06","type":"pipeline","source":"PR Newswire","summary":"Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy - PR Newswire","headline":"Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPcV9RY19Tb1hZZWhLTUh4NzBkM3RaWWJ6c28xQVRVY21mNWlmWXh4UFpvNVI4SjExblRqTmpzU1Ffb3Rxb3dWTjJxdGdkZTZIZEIxQ0Mzek1oTmc5OXo2TnpFSWdpQkVYcnNiTmJIQmJfcWJXSy05b0otUGRvZnVVanJRYW1CNGtDVXdDZF9NWVlNRVUxTDZQN2JQT3NGY3cyV0t0eXNKeVY5X2hTUWJ3UE1PTFdTa01PV1plYWllVVBuR29rTlN4ZVRIWGlKaDR3TWdEdGpOTGlGczF4QlZteEJmbzBJVnl2b1kwQlBTYURVLWNuM1VF?oc=5","date":"2025-09-25","type":"trial","source":"PR Newswire","summary":"Leap Therapeutics to Present Final Clinical Data from Part B of the DeFianCe Study at the ESMO Congress 2025 - PR Newswire","headline":"Leap Therapeutics to Present Final Clinical Data from Part B of the DeFianCe Study at the ESMO Congress 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNMnhJS1o5TE1Fc211WmtvVXpQS0ZtTHFkWmt2Y3BzZ2s4VWJBYlVJU1lIYkVpX3pHUFZXTTgyMWdhYWdKWk1UYjJ3dTFlZmhuSHVmb3NobmJ3SGozQmJ4UmRVcWwyTXhJXzdTa000VDJZV2FTem5nRGlwdDVpRS1WbVp1Zmo1MVRDUlV3MHhfV0VOdFQ4Ty12Uk9ELWVpcm8xRHFUYXJWMFVnSk5HTzA5VWdkemxBOVpiV2M0?oc=5","date":"2025-08-14","type":"earnings","source":"PR Newswire","summary":"Leap Therapeutics Reports Second Quarter 2025 Financial Results - PR Newswire","headline":"Leap Therapeutics Reports Second Quarter 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNTUlYR2V0QWlZVkJsckFfTUVYSTgwTWsxT0RVcGptN19nMV9tX2xiY2dEZW9tcGx2ZW40NUN4MnZhb01YUDI0MVpsbE5sX1Vqb09KWjRYUE1rRjZzT0g1VGIxVXJNeXdKUlBMOWlpQWJiYUZzSGRra3gwMmp0bWRPTTZhSTJvY3QzRV9hNGo4Qk5WYmpWbGlBVi0zQ0JiV3RZdGc?oc=5","date":"2025-06-23","type":"trial","source":"Fierce Biotech","summary":"Leap expands layoffs to cover 75% of employees, scraps only clinical trial to save cash - Fierce Biotech","headline":"Leap expands layoffs to cover 75% of employees, scraps only clinical trial to save cash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxNQ2ppZFU2aV8wd0lrZ2Q3VU1pak5kNl9kcUpJWlJmYnFDN2dWaXN6OU5mbFF0U2NVeHZQZGFuazdOTzh2TzY4N09kRjMyMGZWbkxkTWlQTmtMTGRodXE2MWtEVFJJTFpzS3IyZy04X0pTT0s0dGFVcV9Ic3dTeWcyNkVaRzV4V1JlR2tKYkVHTF9NT21FV2xrbkZFN2xNejc4QXdvQm9USW84bmpuSkczbUVseVd3bVdha2Ixd244R1lYelRESWlhSi1NNENtNkVhaml1YngtZnZkbHd5NVNla3RNcGNGSExoNUhZdjd6U3FGbHB1YWVzM1IxaUN5X0o0WGNRcEJMNTA5LVNXZDdYNFZIaGVhT3N4MHFLUTZmVnpsQQ?oc=5","date":"2025-06-23","type":"trial","source":"PR Newswire","summary":"Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives - PR Newswire","headline":"Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of St","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOWUNPOFV5dXhOMTlKWFRUSXpFQVMwQnJkSmRmNXM2MXZIbU9hS293WWlYYXZsZG84UGFHZUo5VjAydllSMVZ1S0JNTk44eFk4ZVVuVUdkV0Z0YlpxcFAwcTVpUkFuazBWWXdEMGExbkdCUG1QTW5IRWtKUzVjV1Vzd0Z5X2QwWGFoNDNOellESUtQQmx6b0EzRDg4V2dJMnN1YXJwSEx1X0x0UWtvN0RUeVNBdk1yWVNSQ3c?oc=5","date":"2025-05-13","type":"pipeline","source":"Fierce Biotech","summary":"Leap halves head count, narrows lead cancer drug's focus amid 'difficult market environment' - Fierce Biotech","headline":"Leap halves head count, narrows lead cancer drug's focus amid 'difficult market environment'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxNUUxYVlV4NFBuZFowOVlIVHR1R0tBbllueEEwV3JFQnYycFgwemZBSjgyaldyZVlTa1pMeHVIYzB4TEJ2X0JfNWl2RnJhbVRENHdzNkJKalJfaUZLWWJSMV9DRjY3R29nNEk2WFBoN1FROFlWbkNQeXhlTmFpSFBNUTFzNWVxZTZSZmFSSXRmQV9HM1hyampOMmVaM0dBQzNwdFBaSURtSkI5Y3BvTUtrVk5nSkp3amswLXV1aGZMbTRaeFJpc3pGMzNhVXZ0ME9EcDlsOEIzaWk5bTV1MjZZbXdISFU4bTNyelhJd1dnX0RHUno5d3RzeUlaOWtZOTdBRTF0YTlrT2prZ2ZU?oc=5","date":"2025-04-25","type":"trial","source":"PR Newswire","summary":"Leap Therapeutics to Present Preclinical Data of FL-501, a Novel GDF-15 Neutralizing Antibody, at the AACR 2025 Annual Meeting - PR Newswire","headline":"Leap Therapeutics to Present Preclinical Data of FL-501, a Novel GDF-15 Neutralizing Antibody, at the AACR 2025 Annual M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}